A blood-based test with five biomarkers shows high accuracy in distinguishing patients with early-stage pancreatic cancer ...

A Bay Area biotech company is behind a potentially groundbreaking blood test that promises to be a game-changer in cancer ...

Please provide your email address to receive an email when new articles are posted on . The test met its primary endpoint of concordance with intended use, which was 99%. Patients with a positive ...

Testing a person’s blood for a type of protein called phosphorylated tau, or p-tau, could be used to screen for Alzheimer’s disease with “high accuracy,” even before symptoms begin to show, a new ...

The Food and Drug Administration has greenlit Japan-based test manufacturer Fujirebio to begin marketing its blood test for helping doctors diagnose Alzheimer's disease in some patients, clearing the ...

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

ST. LOUIS--(BUSINESS WIRE)--Clinicians worried about early-onset Alzheimer’s disease in patients with cognitive concerns between the ages of 50 and 55 years can now prescribe the PrecivityAD2™ blood ...

Iberdomide, combined with Darzalex and dexamethasone, improves MRD negativity in relapsed multiple myeloma, showcasing CELMoDs' potential in treatment. Early-stage blood cancer diagnosis and ...

Kim M. J. A. Claessen, André P. van Rossum, Ingrid M. C. E. Bolleboom, Jan W. van ‘t Wout, Paul J. W. Dennesen https://www.jstor.org/stable/26526691 Copy URL ...

NHS hospitals are piloting a rapid 15-minute blood test to distinguish viral vs bacterial infections in children ...